List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 114 studies with search of: Darunavir OR Prezista[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed
Has Results 		Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
2 Recruiting A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With TMC114r (Ritonavir), and TMC125 (Etravirine) in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: TMC114 (darunavir);   Drug: TMC114r (ritonavir);   Drug: TMC125 (etravirine)
3 Completed Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: darunavir;   Drug: Ritonavir;   Drug: Etravirine
4 Completed A Pediatric Trial to Provide Dose Recommendation of TMC114/Rtv in HIV-1 Infected Children and Adolescents
Conditions: HIV-1;   HIV Infections
Interventions: Drug: TMC114/rtv Part I and Part II(20-50kg);   Drug: TMC114/rtv Part I and Part II (20-50kg);   Drug: TMC114/rtv Part III (Adult dose>50kg)
5 Recruiting Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Cobicistat;   Drug: Darunavir
6 Recruiting A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Conditions: Human Immunodeficiency Virus (HIV) Infections;   Acquired Immunodeficiency Syndrome (AIDS) Virus
Interventions: Drug: Darunavir;   Drug: Ritonavir
7 Completed TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: TMC114/rtv;   Other: Control Group
8 Unknown † Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Condition: HIV Infections
Interventions: Drug: darunavir, ritonavir, rosuvastatin;   Drug: rosuvastatin, darunavir, ritonavir
9 Completed Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: ritonavir
10 Completed Assessment of Brachial Artery Reactivity in Patients Treated With Darunavir/Ritonavir as Monotherapy and Part of a Highly Active AntiRetroviral Therapy (HAART)
Condition: HIV Infection
Interventions: Drug: darunavir/ritonavir plus investigator's selected NRTIs;   Drug: darunavir and ritonavir
11 Active, not recruiting Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
12 Completed
Has Results 		GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
Conditions: HIV Infections;   Infection
Interventions: Drug: darunavir;   Drug: ritonavir
13 Recruiting TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Adults Coming From Any of the Three Ongoing Tibotec-Sponsored Studies With DRV
Condition: HIV-1 Infections
Interventions: Drug: Darunavir;   Drug: ritonavir
14 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
15 Not yet recruiting Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Condition: HIV Infections
Intervention: Drug: darunavir/ritonavir plus background regimen
16 Active, not recruiting TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Condition: HIV Infections
Interventions: Drug: liquid ritonavir;   Drug: Darunavir tablets;   Drug: Darunavir suspension
17 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir
18 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
19 Completed TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains
Condition: HIV Infections
Intervention: Drug: TMC114
20 Active, not recruiting Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir
Condition: HIV Infections
Intervention: Drug: Switching regimen to raltegravir and darunavir/ritonavir

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services